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Executive summary 
 
This report describes the development and validation of an updating tool to help assess the need and 
likely benefits of updating a Cochrane review. 
 
The Cochrane Collaboration has a policy that Cochrane review authors should agree to update their 
review periodically following its initial publication. Current guidance states this should be done every 
two years, however, there is limited evidence to suggest the ideal time for updating; too soon may 
introduce bias, and if too late, the end user may act on out-of-date or potentially misleading 
information. Given the increasing workload of Cochrane Review Groups and review authors, a 
change to current procedures for updating Cochrane reviews is needed to replace the ad hoc and 
arbitrary approach that currently exists. 
 
In developing this updating tool an international Steering Committee was established to provide 
guidance and support to the project. The tool was developed building on existing empirical evidence 
on updating systematic reviews, guidance in the new Cochrane Handbook for Systematic Reviews of 
Interventions and Review Manager (RevMan) 5, work undertaken by the Cochrane Updating Working 
Group and existing checklists from other agencies, including Cochrane Review Groups. Formal 
piloting and input from users and experts involved in updating Cochrane reviews are being used to 
enhance and refine the tool. 
 
The updating tool is in two parts. Step 1 is a decision tree to identify triggers for updating a Cochrane 
review. Possible triggers include: new evidence, new methods, response to feedback from users of 
the review, or other factors such as the age of the review or its use in policy and guidelines. If review 
authors decide that a trigger is likely to change the conclusions of their review, Step 2 is a checklist 
designed to help review authors consider which sections of their Cochrane review require updating. It 
guides review authors step by step through the review process using questions or triggers, which may 
or may not lead to action and updating of specific sections of the review.  
 
We hope that this updating tool will make it easier to identify which Cochrane reviews are ripe for 
updating and ensure that the decision-making process is made clearer and more transparent to the 
end user. 
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This report describes the development and validation of an updating tool to help assess the need and 
likely benefits of updating a Cochrane review. The report is presented in five sections. Section 1 
describes the background and rationale for the updating tool, including information about when and 
how to update. Section 2 describes the development of the updating tool and the resulting decision 
tree and checklist. Section 3 presents the results of the in-house and ongoing formal pilot of the tool, 
while Sections 4 and 5 provide information about the dissemination of the tool and our key 
conclusions. This project was funded by the Cochrane Opportunities Fund in 2007. 
 
1. Background and rationale for the updating tool 
 
1.1 Definition of updating 
This document and the research underpinning it is predicated on our understanding of what updating 
means. Moher and Tsertsvadze discussed the definition of an update and suggested that “a 
distinguishing feature of an updated systematic review from a new review is that during updating the 
originally formulated protocol (e.g., eligibility criteria, search strategy) is retained, and sometimes 
extended, to accommodate newly identified information (e.g., new treatment type, diagnostic method, 
outcome, different population)” (Moher 2006). This is the definition we are proposing to use when 
discussing updating Cochrane reviews. It draws on the definition used in the new chapter on 
maintaining and updating Cochrane reviews in the Cochrane Handbook for Systematic Reviews of 
Interventions  (Higgins 2008). 
 
1.2 Timeframe for updating 
The Cochrane Collaboration has a policy that Cochrane review authors should agree to update their 
review periodically following its initial publication. Failure to keep Cochrane reviews up to date may 
lead to healthcare decision-makers acting on out-of-date or potentially misleading evidence (Shekelle 
2001). However, the decision to update a Cochrane review needs to be considered carefully. 
Updating too soon may introduce time lag or publication bias, as there is evidence that randomized 
trials with statistically significant results are more likely to be completed sooner and published quicker 
than trials showing statistically negative or inconclusive results (Hopewell 2007). Also, early 
terminated trials showing strong benefit, especially those with small numbers of events, may 
overestimate the underlying treatment effect (Montori 2005). These trials are more likely to be 
published and included in a systematic review (or meta-analysis) earlier than those with a smaller 
effect size or a statistically non-significant result. Furthermore, updating a Cochrane review can 
require a substantial investment in resources and doing this too soon might be an inefficient use of 
the already limited resources available to prepare and maintain Cochrane reviews.  
 
The current guidance for updating Cochrane reviews is that this should be done every two years, but 
this guidance is based more on the wish for findings to appear current and up to date by the end user 
than evidence that this is an appropriate time interval (Middleton 2004). In practice, reviews in rapidly 
moving fields may need to be updated more often than every two years, and other reviews, where the 
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evidence is relatively stable, might require updating less often. A recent assessment of 100 
systematic reviews, published between 1995 and 2005, found that 57% of reviews required updating 
within five years (median 5.5, 95% CI 4.6 to 7.6 years), however, 23% of them had signals of being 
out of date within two years and 15% within one year. The study also found that 7% of reviews had 
signals for updating at the time of publication (Shojania 2007). 
 
1.3 Rationale for updating 
Updating does not just mean adding new research studies. Other factors may need to be considered 
when updating a Cochrane review (Stead 2001). Such factors might include the need to assess new 
treatment regimes, specific new subgroups of populations, or drug comparisons, changes to the costs 
associated with the interventions under review, or the assessment of new outcome measures of more 
importance to patients and other decision makers (some of which may have been assessed by the 
studies already included in the review but not yet incorporated within the review itself).  
 
As the science of systematic reviews develops so do their methods; as new methods of analysing and 
synthesising data become available, the methods of a systematic review need to be assessed to 
ensure that they are still appropriate and up to date. Finally, and perhaps most importantly, it is 
necessary to consider whether the topic under review is still relevant and worthy of updating. For 
example, if a treatment is no longer used for a particular condition or if more effective interventions 
have been developed. Alternatively, if the efficacy of a given treatment has been well established (i.e., 
stability of a statistically significant treatment effect estimate), the addition of new studies is less likely 
to change the pooled results (e.g., effect size, direction) and will result in inefficient use of resources.   
 
1.4 Assessing when to update 
Given the workload of Cochrane Review Groups and authors of Cochrane reviews, a more evidence-
based approach for updating Cochrane reviews is needed to replace the current ad hoc and arbitrary 
approach to updating. However, there is limited evidence about how to improve this approach. For 
example, there is uncertainty about the best methods of assessing when, and if, to update a 
systematic review (Tsertsvadze 2006, Moher 2007) and which criteria could be identified as markers 
for when results of a review should be considered out of date and misleading. Evidence suggests that 
it may not be possible to give a predetermined definitive answer to decide when a Cochrane review 
should be updated (Moher 2007).  
 
To address this uncertainty, we have developed a decision tree (Step 1) and checklist (Step 2) to help 
review teams assess the need and likely benefits of updating a Cochrane review.  
 
1.5 How to update 
Keeping abreast of the literature for a particular Cochrane review helps gauge whether research in a 
particular content area is moving at a fast or slow pace, thus reflecting the need to update a review 
more or less frequently. We believe that the best method for deciding whether, and when, to update a 
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Cochrane review is through continual monitoring of the literature and other sources of information 
relevant to the objectives of the review.  
 
The following surveillance methods have been shown to be efficient ways of helping review authors to 
identify whether new studies have been published. 
 
 Auto Alerts via databases  
Making use of the automatic re-run of the full search strategy by the database service provider every 
time new studies are added to the database; search results are sent automatically via e-mail. 
 Auto Alerts via electronic journals  
Whenever a known relevant study in a particular journal is cited by others these citing references are 
sent automatically via e-mail. 
 PubMed ‘related articles’ feature 
Using a subset of studies (e.g. three largest and three most recent) included in the original Cochrane 
review as ‘seeds’ to search for related articles; restricted to material added to the database since the 
date of the last search and limited to study design (e.g. using the PubMed Clinical Queries option to 
select the ‘therapy’ category for randomized controlled trials) (Sampson 2008). 
 Citation tracking in Citation Indexes 
Using the Science Citation Index or Scopus to search for new studies that cite the original Cochrane 
review; restricted to material added to the database since the date of the last search (Sampson 2008). 
 Searching the Cochrane Review Group’s Specialized Register  
Searching using a subject specific search. 
 
It is recommended that the Auto Alerts are set up when the search strategy is first implemented, by 
the person(s) selected to run the searches (either the review team or the relevant Review Group 
Trials Search Co-ordinator) as it may be preferable to monitor the literature in this way by receiving a 
small number of studies regularly, rather than waiting for 12 or 18 months after the review was 
published and receiving a large number of database records.  
 
To ensure that the auto alerts set up in PubMed/MEDLINE, for example, remain up to date, search 
terms should be checked on an annual basis by the Trials Search Co-ordinator following the US 
National Library of Medicine annual file maintenance programme in which the Medical Subject 
Headings (MeSH) are added to, removed, or amended.  
 
The full search strategy for the review should still be implemented every two years if the auto alert 
facility is not used or for databases which do not offer an auto alert facility. 
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2. Guide to using the updating tool 
 
2.1 Development of the updating tool 
This updating tool has been developed building on existing empirical evidence on updating systematic 
reviews, guidance in the new Cochrane Handbook for Systematic Reviews of Interventions and 
RevMan 5 (Review Manager 2008), work undertaken by the Cochrane Updating Working Group, 
existing checklists from other agencies (including Cochrane Review Groups) and input from users and 
experts involved in updating systematic reviews. Experts who provided advice include: Paul Garner 
and Vittoria Lutje (Cochrane Infectious Diseases Group), Mathew Zacharias, Mike Bennett and Jane 
Cracknell (Cochrane Anaesthesia Group), Phil Wiffen (Cochrane Pain, Palliative and Supportive Care 
Group), Liz Paulsen and Andy Oxman (Cochrane Methodology Review Group), Martin Eccles 
(Cochrane Effective Practice and Organisational Care Group), Jane Clarke (Cochrane Menstrual 
Disorders and Subfertility Group), Sarah Hetrick (Depression, Anxiety and Neurosis Group), Sonja 
Henderson (Cochrane Pregnancy and Childbirth Group), Heather Maxwell (Cochrane Peripheral 
Vascular Diseases Group), Julian Higgins and Sally Green (Handbook Advisory Group), Nandi 
Siegfried (Cochrane HIV/AIDS Group), Alexander Tsertsvadze (Chalmers Research Group), Phil 
Alderson (National Institute for Health and Clinical Excellence), Ton Kuijpers and Jako Burgers (Dutch 
Institute for Healthcare), and Kaveh Shojania (Ottawa Health Research Institute). 
 
2.2 Step 1: decision tree 
Step 1 of the decision tree (see Appendix 1) is designed to help review authors consider possible 
triggers for updating and deciding whether or not to update their review or wait for a longer period of 
time. It is important that the (review team’s) decision-making process about updating is transparent so 
that readers can gain a more complete understanding of the decision-making process regarding 
updating. However, the decision whether, and when to update, is ultimately down to the judgement of 
the review team and / or editorial team (depending on the individual Cochrane Review Group policy).  
 
The most likely trigger for updating a Cochrane review is knowledge of the findings of a new study, 
however, other possible triggers, or combinations of triggers, might include the following: 
 
 New information  
For example, information about new treatment regimes, new population subgroups, harms, economic 
data, or outcome measures, including data from studies that were ongoing when the review was 
prepared previously or data that were missing at that time. 
 New methodology  
For example, new statistical techniques, or changes in the Cochrane Handbook for Systematic 
Reviews of Interventions or RevMan. 
 Response to feedback from users of the review 
 Other factors  
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For example, the age of the review or the imminent use of the review in policy decision-making or the 
development of clinical practice guidelines or both.  
 
At this stage review authors must make a judgement on whether or not a trigger for updating is likely 
or unlikely to change the results or conclusions of a Cochrane review or both. This judgment may 
involve a degree of subjectivity and it is important that it involves all members of the review team and / 
or editorial team (depending on the individual Cochrane Review Group policy). Examples of different 
scenarios where a trigger, such as the identification of a new study, is likely and unlikely to change 
the conclusions of a Cochrane review are described below (also see Appendices 2 and 3). Whatever 
the decision, review authors should briefly describe the process they used. This will provide clarity 
and transparency for readers.   
 
2.2.1 Trigger unlikely to change conclusions 
If a trigger is identified and it is deemed unlikely to change the conclusions of the Cochrane review, 
then the authors might decide not to update the review but undertake an amendment. For example, 
by including the identification of a new study in a Cochrane review whose effect estimate is already 
stable and highly statistically significant, unless it reports new outcomes or information about harms. 
In this case, the ‘What’s new’ section of the review should be updated citing any new studies, if 
appropriate, and why these have not been included at this time. Details of any new studies should 
also be added to the ‘Studies awaiting classification’ section of the review. If appropriate, the 
description of the search methods in both the review’s abstract and body of the text, and the search 
strategies listed in the Appendix should be revised to reflect any amendments to the original search 
methods and strategies used. Further examples of Cochrane reviews where the inclusion of new 
studies or information is unlikely to change the conclusions of a Cochrane review are given in 
Appendix 2. 
 
2.2.2 Trigger likely to change conclusions 
Alternatively, if a trigger is identified which is likely to change the conclusions of a Cochrane review, 
the review should be updated. Examples of such triggers might include the following: 
 
 New study with substantially different results and conclusions than the original Cochrane 
review. 
 New study with a particularly large sample size (especially if the original Cochrane review has 
inconclusive results or contains only a small number of studies). 
 New study with information about an important new comparison, population subgroup, 
outcome or harms not addressed by the studies in the original Cochrane review. 
 New study with a methodological advance not addressed by the studies in the original 
Cochrane review (e.g. a review where previous studies were at high risk of bias due to problems with 
blinding, concealment of allocation, or some methodological issue unique to the topic area). 
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If a trigger is deemed likely to change the conclusions of a Cochrane review, the complete original 
search strategy should be re-run using at least the same databases, to ensure a systematic and 
comprehensive search of the literature. Further examples of Cochrane reviews where the inclusion of 
new studies or information is likely to change the conclusions of a Cochrane review are given in 
Appendix 3. 
 
If the review authors expect that there will never be any further information that could change the 
findings of the review, this should be discussed with the editorial team and a decision can be made 
whether or not to mark this review in The Cochrane Library as ”No longer being updated”. This 
decision should be reported by the review authors. 
 
2.3 Step 2: checklist  
If a review team decides that a trigger, for example a new study or information is likely to change the 
conclusions of their review, Step 2, in the form of a checklist, is designed to help them consider which 
sections of their Cochrane review require updating (see Appendix 4). The checklist aims to guide the 
review team step by step through the review process using questions or triggers, which may or may 
not lead to action and updating. The empirical evidence for this action is indicated, where available. 
We welcome reference to additional evidence to inform the use of the checklist items from review 
authors and others involved in helping to keep Cochrane reviews up to date.   
 
We believe that to be used optimally the checklist should be completed by the review team for each 
review and indeed should be seen as an essential part of the review publication procedure (that is, 
included as part of the review report). 
 
3. Validation of the updating tool 
 
3.1 In-house piloting of the updating tool  
During July 2007, we conducted an in-house pilot to test the validity and reliability of the updating tool 
in assessing the need and likely benefits of updating a Cochrane review. Ten Cochrane reviews from 
Issue 4, 2007 of The Cochrane Library, which had recently been updated, were selected at random: 
five had been categorised as major updates and five had been categorised as minor. Major indicated 
a substantive update (i.e. a review that the authors and Review Group wished to highlight as a review 
that should be read again by people who had read it before, usually because of a change in 
conclusions). One person (without knowledge of the updated review), used the updating tool to 
determine if the original version needed updating. The following search strategy was deployed: 
 
 Phase 1: PubMed ‘related articles’ feature: using a subset of studies (e.g. three largest and 
three most recent) included in the original Cochrane review as ‘seeds’ to search for related 
articles; restricted to material added to the database since the date of the last search and 
 11 
limited to study design (e.g. using the PubMed Clinical Queries option to select the ‘therapy’ 
category for randomized controlled trials). 
 
If no potential new studies were identified then Phases 2 and 3 of the search strategy were deployed: 
 
 Phase 2: Citation tracking in Citation Indexes: using the Science Citation Index to search for 
new studies that cite the original Cochrane review; restricted to material added to the 
database since the date of the last search. 
 Phase 3: Searching the Cochrane Review Group’s Specialized Register: using a subject 
specific search.  
 
The decision tree (see Appendix 1) was then used to determine possible triggers for updating. If a 
trigger, for example the availability of a new study, was deemed likely to change the conclusions of 
the review, the updating checklist (see Appendix 4) was used to help determine which sections of the 
review required updating. The original version of the review was then compared to the updated 
version to determine if the updating tool had been successful. 
 
Using the decision tree, six of the ten reviews were deemed as not requiring updating and four should 
be updated (i.e. the addition of new evidence or new methods was likely to change the conclusions of 
the review). However, on checking the actual categorisation of the updated review (major or minor) 
one review had been determined as being a major update but this decision was not confirmed as only 
one additional study was located and the evidence was inconclusive. We believe the incorrect 
category had been determined by the review authors on submitting their review. Another review had 
been correctly determined as requiring an update but there was, in fact, no change in conclusions. 
Phase 1 of the search strategy picked up 100% of included studies (i.e. no further studies for inclusion 
were detected through Phase 2 or Phase 3) (Table 1).  
 
Based on the findings of this small in-house pilot, the updating tool appears to be effective in 
determining whether updating should go ahead. Phase 1 of the search strategy may be sufficient to 
determine if there are new included studies, especially if there are difficulties getting access to citation 
tracking. However, Phases 2 and 3 do allow confirmation of Phase 1 and are, therefore, still included 
as a recommendation for monitoring the literature.  
 
We recommend that two review authors independently read through titles and abstracts to ensure that 
no included studies are missed. The ‘Criteria for selecting studies for this review’ should also be used 
carefully to determine the inclusion of any potentially relevant studies, however, it can be hard to 
detect new data, outcomes or concerns if the review authors are not an expert on the subject. There 
may also be a problem assessing articles for inclusion because of vague comparison information 
provided in the review (e.g. “miscellaneous” in one review was not made explicit). 
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Table 1: Success of the three different search strategy phases to locate new studies  
 
Name of Cochrane review 
 
Phase 1 Phase 2 Phase 3 Tool Updated 
review 
Caesarean delivery for the second twin    Minor Minor 
Calcium antagonists as an add-on therapy for drug-
resistant epilepsy 
   Minor Minor 
Prophylactic antibiotics for preventing early central 
venous catheter Gram positive infections in oncology 
patients 
√   Minor Substantive 
Mobilisation strategies after hip fracture surgery in 
adults 
√   Substantive Substantive 
Iron-chelating agents for treating malaria √   Minor Minor 
Conservative management for postprostatectomy 
urinary incontinence 
√   Substantive Substantive 
Cooling for newborns with hypoxic ischaemic 
encephalopathy 
√   Substantive Substantive 
Vitamin A supplementation to prevent mortality and 
short and long-term morbidity in very low birthweight 
infants 
√   Substantive Substantive 
Complementary and miscellaneous interventions for 
nocturnal enuresis in children 
   Minor Minor 
Interventions for asymptomatic retinal breaks and 
lattice degeneration for preventing retinal detachment 
   Minor Minor 
 
√ new studies found 
 
3.2 Formal piloting of the updating tool 
Following successful collaboration with many entities and input from Cochrane and non-Cochrane 
experts on updating, we have circulated the updating tool wider to eight Cochrane Review Groups 
and 14 review authors who have expressed an interest in pilot testing the decision tree and checklist. 
The following Cochrane Review Groups are participating in the formal pilot: Methodology Review 
Group, Effective Practice and Organisation of Care, Anaesthesia, Renal, Breast Cancer, Back, 
Consumers and Communication, and Oral Health. 
 
Testers have been asked to use the updating tool whilst updating any Cochrane reviews in the 
coming months, telling us how the tool helped or hindered the process. Importantly, as this is part of 
the piloting process testers are asked to use the tool alongside and not instead of their normal 
updating process and not necessarily to use the decision tree to decide whether or not to update. 
Testers have been asked to complete a questionnaire about their experiences of using the tool which 
they have been asked to return once they have completed their update. We anticipate that the formal 
pilot will be finished in April 2009, but we may have to wait until July 2009 to receive all feedback from 
pilot testers updating reviews. 
 
4. Dissemination of the updating tool 
The initial findings for this project were presented at the Cochrane Colloquium in Freiburg (Loudon 
2008) in October this year, where the updating tool was well received and resulted in several more 
Cochrane Review Groups expressing an interest in piloting the tool.  
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Following the results of the formal pilot, and any refinement of the tool, we hope to enter into 
discussions with the Cochrane Editor-in-Chief, the Handbook Advisory Group and the Quality 
Advisory Group about the possibilities of suggesting changes to updating procedures and 
incorporating the tool into the Cochrane Handbook for Systematic Reviews of Interventions. If 
appropriate, we should also like to discuss ways of incorporating these recommendations into training 
programmes for systematic reviews run within The Cochrane Collaboration, such as the updating 
workshops run by the UK Cochrane Centre and Australasian Cochrane Centre. We will also seek to 
make the resources available electronically via the internet for review authors to download. 
 
We also plan to make the updating tool available to agencies involved in the production of evidence 
synthesis, including the Expert Working Group on Updating Systematic Reviews (Thomas Chalmers 
Research Institute, Canada), the UK Health Technology Assessment Programme and the National 
Institute for Health and Clinical Excellence (UK) who have all given feedback during the development 
of the tool. Finally, we intend to publish the updating tool and the results of the formal pilot in a peer-
reviewed journal. 
 
In the longer term, further work is needed to develop this tool and to try to incorporate statistical 
techniques to identify when the addition of new studies is likely change the results of individual meta-
analyses within Cochrane reviews. We are in discussion with Alex Sutton (Cochrane Statistical 
Methods Group) at the University of Leicester about the potential for incorporating a statistical 
updating prioritisation tool (Takwoingi 2008), which he and colleagues are developing, and which has 
been piloted by the Cochrane Infectious Diseases Group.  
 
5. Conclusion 
The Cochrane Opportunities Fund has enabled this extremely important project to go ahead, which 
has resulted in the development of an updating tool to produce new methods to guide decisions of 
whether, and when, to update Cochrane Reviews. We anticipate that this will facilitate updating at the 
appropriate time and will minimise unnecessary updating. This should lead to improvements in the 
quality and reliability of healthcare decisions made on the basis of ‘current’ evidence. 
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Appendix 1 - Decision tree for whether, and when, to update a Cochrane review 
 
NO 
NO 
Is there any new 
feedback? 
(e.g. reader comments) 
Is there any new 
methodology? 
(e.g. new statistical analysis, 
change in Handbook or RevMan) 
Unlikely to change 
conclusions 
(e.g. new study in a Cochrane review 
whose effect estimate is already stable 
and highly statistically significant) 
Is there a new study? 
Is there any other new 
information? 
(e.g. new treatment  regimen, harms, 
new population sub-groups, new 
outcome measure, data from ongoing 
studies or previously missing data) 
Are there any other 
new factors? 
(e.g. age of review, imminent 
policy or guidelines) 
NO 
NO 
NO 
Update ‘What’s new’ 
(cite reasons for not updating at this time) 
YES 
Update ‘What’s new’ 
1. cite any new studies and why they 
were not included 
2. add to ‘Studies awaiting 
classification’ 
3. update search dates, search methods, 
and search strategies (where 
appropriate)  
The decision tree should be read in conjunction with the checklist 
Update review by 
incorporating new 
evidence 
(use checklist) 
Likely to  
change conclusions  
(e.g. new study with: substantially 
different results and conclusions; 
particularly large sample size; 
information about an important new 
comparison, population subgroup, 
outcome or harms; or, a methodological 
advance not addressed by studies in the 
original Cochrane review) 
YES 
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Appendix 2 - Example of trigger unlikely to change conclusions 
 
Example of a Cochrane review where the inclusion of new studies or evidence is unlikely to change 
the conclusions of a Cochrane review. 
 
 
 
 
 
Chen W, Liu J, Gluud C. Bile acids for viral hepatitis. Cochrane Database of Systematic Reviews 2007, Issue 4. 
Art. No.: CD003181. DOI: 10.1002/14651858.CD003181.pub2. 
Bile acids for viral hepatitis 
2002: review had 28 included studies (2034 pts) 
Conclusions: Bile acids leads to a significant 
improvement in serum transaminase activities in 
hepatitis B and C (RR 0.82, 95% CI 0.76 to 
0.90) 
 
Bile acids for viral hepatitis 
2007: review had 29 included studies (2094 pts) 
Conclusions: Bile acids leads to a significant  
improvement in serum transaminase activities in  
hepatitis B and C (RR 0.82, 95% CI 0.76 to 
0.90) 
 
New study 
 
(n = 1) 60 pts 
This new study is small and 
since the original review 
had highly significant 
results, is unlikely to 
change the conclusions 
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Appendix 3 - Example of trigger likely to change conclusions 
 
Example of a Cochrane review where the inclusion of new studies or evidence is likely to change the 
conclusions of a Cochrane review. 
 
 
 
Nicholson AB. Methadone for cancer pain. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: 
CD003971. DOI: 10.1002/14651858.CD003971.pub3. 
 
 
Methadone for cancer pain 
2003: review had 8 included studies (356 pts) 
Conclusions: There is no trial evidence to 
support the proposal that methadone has a 
particular role in neuropathic pain of malignant 
origin. 
Methadone for cancer pain 
2007: review had 9 included studies (459 pts) 
Conclusions: The updated review contains 
new information supporting the previous 
conclusions. The additional study examined 
neuropathic and non-neuropathic pain, finding 
no superiority for methadone in the former 
group. The new study also addressed a 
clinically relevant concern … use of 
methadone beyond a few days may result in 
methadone accumulation leading to delayed 
onset of adverse events. 
 
New study & 
new outcome 
(n = 1) 103 pts 
This new study increased the 
total number of participants 
by 1/4 and also included new 
outcome information, so is 
likely to change the 
conclusions 
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Appendix 4 - Checklist for updating a Cochrane review 
It is recommended that the checklist should be completed by the review team for each review and indeed should be seen as an essential part of the updating 
review publication procedure. 
 
Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
1 Title Is the review topic still relevant? 
 
If no: do not update the review, 
merge it with another review, 
split the review. This should be 
discussed with the editorial 
team. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
2 Review information 
2a Authors Are the review authors willing to 
update the review and do they 
have time to do so? 
 
Is a new team of review authors 
needed to update the review? 
If a new team of review 
authors will update the review, 
any original authors who are 
not involved in the update 
should be recorded in the 
‘Acknowledgements’ section. 
 
Cochrane Infectious Diseases Group Review 
Update Checklist 2007 
 
Linde 2006 
 
2b Contact person 
 
Are details correct? If no: revise or edit as 
necessary. 
Cochrane Infectious Diseases Group Review 
Update Checklist 2007  
 
 
2c Dates Do any of the date fields in 
RevMan need updating?  
If yes: edit field date review 
was last ‘Assessed as Up to 
date’, ‘Date of Search’ and 
‘Next Stage Expected’. 
 
Cochrane Handbook for Systematic Reviews 
of Interventions 
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Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
2d What’s new section  Has anything new been added to 
the review? 
(e.g. new study, new evidence, 
response to feedback) 
If yes: edit ‘What’s new’ field. 
Select type of ‘Event’ and 
‘Description’ of what new 
information has been added to 
the review e.g. state what has 
been done (for example, 
number of studies, participants 
or extra analyses) and any 
important changes to 
conclusions, results or 
methods of the review. Also 
insert ‘Date’. 
 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
Cochrane Infectious Diseases Group Review 
Update Checklist 2007 
 
 
 
2e History Are previous ‘What’s new’ 
included in this section? 
If no: update as necessary.   
 
3 Abstract Has review been updated and 
changed? 
If yes: revise the abstract in 
accordance with changes to 
the review.  
 
Include an introductory 
sentence in the Background 
saying: “This is an updated 
version of the original 
Cochrane review published in 
Issue X, YEAR.”  
 
In the Conclusions of the 
abstract include a sentence 
saying whether, since the last 
version of the review, any new 
studies have been found, if the 
conclusions have changed, 
and if the user should re-read 
the review.  
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
Cochrane Pain, Palliative and Supportive Care 
Group. Information to help review authors 
update their Cochrane review 2008 
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Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
4 Plain language 
summary 
Has review been updated? If yes: revise the summary in 
accordance with changes to 
the review.  
 
  
      
5 Background Are there changes in policy and 
strategic practice that affect the 
context of the review? 
If yes: revise this section to 
reflect the changes. Include an 
introductory sentence saying 
“This review is an update of a 
previously published review in 
The Cochrane Database of 
Systematic Reviews (Issue X, 
Year) on ‘Title’”. 
 
Cochrane Handbook for Systematic Reviews 
of Interventions  
 
Cochrane Pain, Palliative and Supportive Care 
Group. Information to help review authors 
update their Cochrane review 2008 
 
 
 
6 Objectives Is the research question still 
relevant? 
(e.g. is the intervention still used, 
has the treatment regime 
changed, has the health problem 
been eradicated) 
If yes: revise objectives and 
state the rationale for the 
change in the ‘What’s new’ 
section. 
If no: state this in the ‘What’s 
new’ section and provide 
rationale for not updating. This 
should be discussed with the 
editorial team. 
  
Cochrane Infectious Diseases Group Review 
Update Checklist 2007 
 
Linde 2006  
 
 
 
7 Methods 
Criteria for selecting studies for this review 
7a Types of studies Is the study design still 
appropriate? 
(e.g. the inclusion of non-
randomized trials for harms) 
If no: revise this section, 
modify the search strategies in 
the Appendix as necessary 
and provide the rationale for 
change. 
 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
Linde 2006 
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Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
7b Types of 
participants 
Is the population still relevant? 
(e.g. has a study been published 
which opens up the original 
question to include all age 
ranges, less or more specific 
categories, people from 
developing countries) 
 
Are important exclusions 
described? 
If no: revise this section, then 
modify the search strategies in 
the Appendix as necessary 
and provide the rationale for 
change. 
 
Linde 2006 
 
Cochrane Consumers and Communication 
CRG Checklist 2007 
 
7c Types of 
interventions 
Is the intervention(s) still used, or 
have the treatment or drug 
comparisons changed? 
 
If changes are needed: revise 
this section, include new 
comparisons, modify the 
search strategy as necessary 
and provide the rationale for 
change. 
 
Cochrane Handbook for Systematic Reviews 
of Interventions  
 
Linde 2006 
 
7d Types of outcome 
measures 
Is there evidence which includes 
important new outcome 
measures?  
(e.g. quality of life outcomes, 
harms, economic analysis) 
 
Are important exclusions 
described? 
If yes: revise this section, 
modify the search strategy as 
necessary and provide the 
rationale for change. 
 
Cochrane Infectious Diseases Group Review 
Update Checklist 2007 
 
Linde 2006 
 
Cochrane Consumers and Communication 
CRG Checklist 2007 
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Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
Search methods for identification 
7e Search methods for 
identification of 
studies  
Have any new studies been 
reported?  
 
Rerun full search strategy 
every two years (if auto alerts 
are not used or in databases 
that do not offer an auto alert 
facility). 
 
 
These methods have been proposed as 
triggers for whether new studies have been 
published: 
 Auto Alerts via databases (i.e. automatic re-
run of full search strategy every time new 
studies are entered into a database, search 
results automatically sent by e-mail) 
 Auto Alerts via journals (i.e. whenever a 
known relevant study in a journal is cited by 
others the citing references are 
automatically sent by e-mail)  
  PubMed ‘related articles’ feature (e.g using 
the three largest and three most recent 
studies included in the original Cochrane 
review as ‘seeds’ to search for related 
articles; restricted to material added to the 
database since the date of last search and 
limited to study design publication type 
(Sampson 2008)) 
 Citation tracking (e.g. using Science 
Citation Index or Scopus to search for new 
studies that cite the original Cochrane 
review; restricted to material added to the 
database since the date of last search 
(Sampson 2008)) 
 Searching the CRG Specialized Register 
 
The terms in the search strategy should be 
checked regularly (annually in MEDLINE) for 
changes introduced by database producers 
and the strategy amended accordingly to 
ensure that the auto alerts are kept up to date. 
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Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
    Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
  Is original search strategy 
suitable or does it need to be 
modified due to changes in 
criteria for selecting studies or 
terminology? 
 
If yes: revise the details given 
for the search methods in the 
text of the review and for the 
search strategies in the 
Appendix). 
National Library of Medicine makes changes to 
MeSH terms annually so may need to modify 
original search strategy (US National Library of 
Medicine 2006; US National Library of 
Medicine 2007) 
 
 
  Does the date of last search need 
updating? 
If yes: revise the dates given 
for each database and other 
sources as necessary in the 
text of the review and the 
Appendix. 
 
Report actual date of search, 
rather than simply the month 
and year. 
 
A single date should be given 
in the ‘Date of search’ field to 
indicate when the most recent 
comprehensive update search 
was started 
Specifying the date, not just month and 
publication year enables more complete 
retrieval of records thereby minimizing 
publication bias (Bergeroff 2004; Moher 2007). 
It is advisable to seek the guidance of the 
Trials Search Co-ordinator in selecting the best 
method to limit the search to the specific date 
when the search was last re-run for each 
database. 
 
Cochrane Handbook for Systematic Reviews 
of Interventions Chapter 3: Section 3.3.3 
 
Data collection and analysis 
7f Data collection and 
analysis  
Systematic review methods are 
susceptible to change based on 
the findings of methodological 
research and other 
developments. 
 
Are the systematic review 
methods used in the original 
review still appropriate?  
Check RevMan and the 
Cochrane Handbook to see if 
there have been changes 
since the review was last 
published. If there have been 
changes, the review authors 
might wish to revise this 
section. 
 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
Linde 2006 
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Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
8 Results 
8a Description of 
studies 
Have any additional included, 
excluded or ongoing studies been 
identified? 
If yes: revise accordingly. 
 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
8b Risk of bias in 
included studies  
Are the methods of assessing 
methodological quality used in 
the original review still 
appropriate?  
(e.g. the introduction of the new 
‘Risk of Bias’ table) 
If no: revise accordingly. 
 
 
 
 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
8c Effects of 
interventions 
Qualitative analysis 
 
If it was not possible to conduct a 
meta-analysis, does the addition 
of new studies change the results 
in some way? 
If yes: describe any changes 
qualitatively. 
 
 
Shojania 2007 
 
 
  Quantitative analysis 
 
If conducting a meta-analysis, 
does the addition of new studies 
change the statistical significance 
of the results? 
If yes: revise accordingly. 
 
There are several statistical methods, using 
cumulative meta-analysis (CMA), for 
identifying whether the addition of new studies 
will change the results of a meta-analysis. 
Currently no particular tool is recommended, 
further research is needed (Moher 2007). 
 Identifying “null” meta-analysis ripe for 
updating. A formula based on the number 
of participants in new included study 
(Barrowman 2003).  
 Conventional CMA (Baum 1981; Lau 1992; 
Lau 1995; Berkey 1996; Moher 2007). 
CMA using the cumulative slope as an 
indicator of stability. The smaller the 
magnitude of the slope of the regression 
line, the greater the confidence that the 
pooled effect size is becoming stable, 
suggesting no need for further updating  
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Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
    (Mullen 2001). 
 CMA using sequential monitoring 
boundaries. Calculating prospectively the 
amount of additional information needed to 
determine whether or not to update (Pogue 
and Yusef 1997). 
 Recursive CMA (Ioannidis 1999; Ioannidis 
and Lau 2001; Moher 2007). 
 
 
    Several other quantitative methods have been 
proposed as triggers for updating: 
 If the sample size of the new  study is three 
times as large as the largest previously 
published trial (Shojania 2007). 
 If the relative change in effect magnitude 
is at least 50% involving one of the 
primary outcomes of the original review or 
any mortality outcome (Shojania 2007). 
 
 
 
9 Discussion Are there changes in other 
sections of the review which 
should be reflected in the 
discussion? 
If yes: revise in light of the new 
findings. 
 
  
 
10 Authors’ 
conclusions 
Are there changes in other 
sections of the review which 
should be reflected in the 
conclusions? 
If yes: revise in light of the new 
findings. 
 
An increase in precision (narrower confidence 
interval) and change in statistical significance 
is predictive for changing conclusion of a 
review (French 2005). 
 
 
11 Acknowledgements Are there new review authors? If yes: add these and 
acknowledge the contributions 
of any previous review authors 
who have been removed from 
the by-line. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
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Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
12 Contributions of 
authors 
Have there been any changes to 
the contributions of authors 
during the update? 
 
If yes: edit the contributions 
section of the review. 
Cochrane Handbook for Systematic Reviews 
of Interventions  
Cochrane Infectious Diseases Group Review 
Update Checklist 2007 
 
 
13 Declarations of 
interest 
Are there any changes in conflict 
of interest? 
If yes: include additional 
information. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
14 Difference between 
protocol and review 
Are there any changes between 
the original protocol and the 
updated review? 
 
If yes: include additional 
information. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
15 Published notes  Are there important editorial 
changes that should be 
documented? 
If yes: make the necessary 
changes. (For example, a 
review might have been 
suspended, withdrawn, or 
merged). 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
16 Characteristics of 
included studies 
table 
Have new included studies been 
added? 
If yes: add details of these to 
this table. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
17 Characteristics of 
excluded studies 
table 
Have new excluded studies been 
identified? 
If yes: add details of these to 
this table. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
18 Risk of bias table Have new included studies been 
added? 
If yes: add details of these to 
this table. 
 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
19 Characteristics of 
ongoing studies 
table 
Have new ongoing studies been 
identified? 
 
If yes: add details of these to 
this table. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
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Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
20 Summary of 
findings table 
Have new included studies been 
added? 
If yes: add details of these to 
this table. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
21 Additional tables Has new data (from new included 
studies or other sources as 
relevant) been identified?  
 
If yes: add the data to this 
table.  
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
22 References to 
studies 
Are there any additional ongoing 
trials or trials awaiting 
assessment, or has a version of 
the review been published 
elsewhere? 
 
If yes: add the relevant 
references. (Knowing when an 
ongoing trial is due to end may 
trigger the need for next 
updating the review.) 
  
 
23 Data and analyses Has data from new included 
studies been identified? 
 
If yes: add the data to this 
table. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
24 Figures Have new included studies been 
added? 
If yes: add details as 
appropriate. 
 
  
 
25 Sources of support Are there any changes in sources 
of support? 
 
If yes: include additional 
information. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
 
 
26 Feedback Has there been any feedback (or 
comments and criticism) on the 
review? 
 
If yes: address the issue(s) as 
appropriate. 
Cochrane Handbook for Systematic Reviews 
of Interventions 
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Number Section of review 
 
Question / trigger Updating Action Source of advice, guidance or evidence Tick if 
item 
updated 
27 Appendices Have new search strategies been 
required to cover changes to 
types of participants, 
interventions, outcomes etc? Or 
as a result of changes to 
database subject headings 
introduced by database 
providers? 
 
If yes: copy and paste full 
search strategies as 
implemented for each 
database searched, together 
with the line numbers for each 
search set, in an appendix to 
the review 
Cochrane Handbook for Systematic Reviews 
of Interventions 
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